Automated breast ultrasound one step closer to FDA approval

Editorial Staff | | Health Imaging | Diagnostic Imaging
U-Systems has received a pre-market approvable (PMA) letter from the FDA for its somo•v Automated Breast Ultrasound (ABUS) system for breast cancer screening as an adjunct to mammography for asymptomatic women with dense breast tissue. 

Using technology to automate the ultrasound imaging process, the U-Systems’ somo•v ABUS system was developed for the high-volume, breast cancer screening environment. The somo•VIEWer Advanced 3D Workstation enables review and archive of patient exams.

Final approval of the company’s PMA application for the system remains subject to satisfactory review and inspection of U-Systems manufacturing facilities, methods and controls. The company said it plans to work with the FDA to complete this final inspection.

 

Editorial Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.